Physician profile
Simra Ahmed
NPI 1790288769
$2,231.48
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $327 · 2022: $243 · 2023: $1,147 · 2024: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $478.56 | 2023-2024 | Lipiflow System Activator II (Disposable, Lipiview Ocular Surface Interferometer, Meibomian Gland Evaluator |
| Alcon Vision LLC | $407.99 | 2021-2024 | Argos, Centurion, Hydrus Microstent |
| Regeneron Healthcare Solutions, INC. | $359.67 | 2022-2024 | Eylea Hd |
| Abbvie INC. | $175.03 | 2022-2023 | Xen Glaucoma Treatment System, Ozurdex |
| Genentech USA, INC. | $171.38 | 2023 | Vabysmo |
| Genentech, INC. | $143.28 | 2023 | Vabysmo |
| Amgen INC. | $122.85 | 2024 | Tepezza |
| Apellis Pharmaceuticals, INC. | $121.86 | 2023 | Syfovre |
| Aerie Pharmaceuticals, INC. | $116.53 | 2021 | |
| Biotissue Holdings INC. | $104.02 | 2023 | |
| Ani Pharmaceuticals, INC. | $30.31 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simra Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.